Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cymbria Corp | CYOA | Nov 13, 2024 | 51.50 | 0.00 |
CYNATA THERAPEUTICS LTD Ordinary Shares(Australia) | 51S | Nov 13, 2024 | 0.13 | +1.54 |
Cytokinetics, Incorporated | KK3A | Nov 13, 2024 | 53.00 | 0.00 |
Cytomed Therapeutics | F98 | Nov 13, 2024 | 2.06 | -5.50 |
CytomX Therapeutics, Inc. | 6C1 | Nov 13, 2024 | 0.88 | +1.68 |
Cytosorbents Corporation | HQE1 | Nov 13, 2024 | 0.90 | +7.11 |
Cyviz | 8P9 | Nov 13, 2024 | 2.42 | -1.22 |
Cyxone | 4CX | Nov 13, 2024 | 0.00 | 0.00 |
CZG - Ceska Zbrojovka Group SE | 6QS | Nov 13, 2024 | 24.90 | +1.22 |
D Amico International Shipping | B7C0 | Nov 13, 2024 | 4.34 | +1.76 |
D-Box Technologies Inc. | DB2 | Nov 13, 2024 | 0.06 | +40.00 |
D-Market Electronic Services & Trading ADR | 8WZ | Nov 13, 2024 | 2.76 | -2.13 |
D-Wave Quantum | RQ0 | Nov 13, 2024 | 1.69 | +12.35 |
D.R. Horton, Inc. | HO2 | Nov 13, 2024 | 151.26 | -3.14 |
D.Western Therapeutics Institute, Inc. | 6DW | Nov 13, 2024 | 0.31 | -4.85 |
D/B/A Centerspace | WXC1 | Nov 13, 2024 | 70.00 | +1.45 |
D/B/A Royal Caribbean Cruises Ltd. | RC8 | Nov 13, 2024 | 223.00 | +0.91 |
D/B/A Sibanye-Stillwater Limited ADS | 47VS | Nov 13, 2024 | 3.80 | -1.04 |
D/S Norden | D69 | Nov 13, 2024 | 28.02 | -4.50 |
D4t4 Solutions Plc | 5H9 | Nov 13, 2024 | 3.54 | 0.00 |
DA MING INTL | DM7 | Nov 13, 2024 | 0.08 | 0.00 |
DACHAN FOOD | 3DS | Nov 13, 2024 | 0.06 | +0.81 |
Dada Nexus Limited - American Depositary Shares | D0A | Nov 13, 2024 | 1.44 | -5.26 |
Dadelo SA | 91N0 | Nov 13, 2024 | 4.79 | +0.63 |
DAH SING | DSR | Nov 13, 2024 | 2.92 | 0.00 |
DAHSING BANKING | RY2 | Nov 13, 2024 | 0.85 | -1.16 |
DAI NIPPON P. SP.ADR 1/2 | DNP0 | Nov 13, 2024 | 7.65 | -1.92 |
Dai Nippon Printing Co Ltd | DNP | Nov 13, 2024 | 15.70 | -2.48 |
Dai-ichi Life Holdings Inc | QHH | Nov 13, 2024 | 25.40 | +0.79 |
Daicel Corporation | 9DC | Nov 13, 2024 | 8.05 | -3.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.